These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2459842

  • 1. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
    Flexner C, Broyles SS, Earl P, Chakrabarti S, Moss B.
    Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
    [Abstract] [Full Text] [Related]

  • 2. Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus.
    Gowda SD, Stein BS, Steimer KS, Engleman EG.
    J Virol; 1989 Mar; 63(3):1451-4. PubMed ID: 2464705
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Mar; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 4. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.
    Shioda T, Shibuta H.
    Virology; 1990 Mar; 175(1):139-48. PubMed ID: 1689917
    [Abstract] [Full Text] [Related]

  • 5. Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
    Dru A, Ludosky MA, Cartaud J, Beaud G.
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):383-90. PubMed ID: 7520722
    [Abstract] [Full Text] [Related]

  • 6. Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus.
    Gowda SD, Stein BS, Engleman EG.
    J Biol Chem; 1989 May 25; 264(15):8459-62. PubMed ID: 2785991
    [Abstract] [Full Text] [Related]

  • 7. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Karacostas V, Nagashima K, Gonda MA, Moss B.
    Proc Natl Acad Sci U S A; 1989 Nov 25; 86(22):8964-7. PubMed ID: 2479031
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B.
    Virology; 1993 Apr 25; 193(2):661-71. PubMed ID: 7681610
    [Abstract] [Full Text] [Related]

  • 9. Immune response of mice infected with recombinant vaccinia viruses carrying the HIV gag gene.
    Sugata F, Aoki N, Shioda T, Hayashi T, Shimada K, Mitamura K, Shibuta H.
    Microbiol Immunol; 1991 Apr 25; 35(10):849-61. PubMed ID: 1779889
    [Abstract] [Full Text] [Related]

  • 10. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R, Fliessbach H, Wanner G, Motz M, Niedrig M, Deby G, von Brunn A, Wolf H.
    Arch Virol; 1992 Apr 25; 127(1-4):117-37. PubMed ID: 1456888
    [Abstract] [Full Text] [Related]

  • 11. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.
    Hu SL, Travis BM, Garrigues J, Zarling JM, Sridhar P, Dykers T, Eichberg JW, Alpers C.
    Virology; 1990 Nov 25; 179(1):321-9. PubMed ID: 2219727
    [Abstract] [Full Text] [Related]

  • 12. [Expression of gag gene of human immunodeficiency virus in recombinant vaccinia virus].
    Popov SA, Barsov EV, Bukrinskiĭ MI, Zhdanov VM.
    Mol Gen Mikrobiol Virusol; 1988 Sep 25; (9):36-9. PubMed ID: 3264887
    [Abstract] [Full Text] [Related]

  • 13. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
    Hoshikawa N, Kojima A, Yasuda A, Takayashiki E, Masuko S, Chiba J, Sata T, Kurata T.
    J Gen Virol; 1991 Oct 25; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
    [Abstract] [Full Text] [Related]

  • 14. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP, Booth TF, Belyaev AS, McIlroy D, Jowett J, Roy P.
    Virology; 1993 Mar 25; 193(1):242-55. PubMed ID: 8438569
    [Abstract] [Full Text] [Related]

  • 15. Morphogenesis of recombinant HIV-2 gag core particles.
    Voss G, Kirchhoff F, Nick S, Moosmayer D, Gelderblom H, Hunsmann G.
    Virus Res; 1992 Jul 25; 24(2):197-210. PubMed ID: 1529643
    [Abstract] [Full Text] [Related]

  • 16. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
    Marcus-Sekura CJ, Woerner AM, Klutch M, Quinnan GV.
    Biochim Biophys Acta; 1988 Feb 28; 949(2):213-23. PubMed ID: 2449245
    [Abstract] [Full Text] [Related]

  • 17. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY, Jin NY, Wang HW, Guo ZR, Fang HH, An RG, Yin Z.
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan 28; 16(1):65-8. PubMed ID: 10883279
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
    Kent SJ, Stallard V, Corey L, Hu SL, Morton WR, Gritz L, Panicali DL, Greenberg PD.
    AIDS Res Hum Retroviruses; 1994 May 28; 10(5):551-60. PubMed ID: 7917517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.